David Krempa | Senior Vice President, Business Development & Investor Relations |
Sean Brynjelsen | Chief Executive Officer |
Wilson Troutman | Chief Financial Officer |
Kevin Guthrie | Executive Vice President-Commercial Activities |
Mitchell Kapoor | H.C. Wainwright |
Justin Walsh | B. Riley Securities |
Good evening, and welcome to the Eton Pharmaceuticals Fourth Quarter 2021 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call up to your questions. Please be advised that this call is being recorded at the company's request. At this time, I’d like to turn it over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals.